Next-Generation ImmunoTherapies

Cutting Through
Complexity

Pioneering programmable off-the-shelf therapeutics to enhance the immune system and fight disease with precision, safety and scalability

The future of immunotherapy

Off-the-shelf alternative

Our platform enables readily available, cost-efficient therapeutics that remain competitive with existing biologics while eliminating the complex, patient-specific manufacturing challenges of cell therapies

No genotoxicity risk

Our proprietary approach enables durable therapeutic effects through low immunogenic epigenetic editing platform, achieving long-lasting gene modulation without DNA damage or risk of secondary malignancies

Access to undruggable targets

This approach enables access to multiple targets, both traditionally druggable and previously undruggable, to reactivate the patient's natural anti-tumor immune response

Precision delivery platform

Precision Delivery Platform Zoom Process
1
Stealth epigenetic editor Prevents immunorejection of the reprogrammed cells
2
Tuned nanocarrier architecture First layer of specificity, optimized for preferential organ delivery
3
Targeted binder engineering Enables refined cellular targeting and uptake based on surface markers
4
Engineered cell-specific sensing payloads Allows discrimination between similar cell types for enhanced specificity
5
Selective target gene identification Careful target selection minimizes off-target effects to enhance the overall safety profile

Let's connect

Interested in partnering, investing, or learning more about us?